Our study confirmed that CENPA is highly expressed in high-risk NB samples and is associated with poor prognosis, suggesting that CENPA may be involved in the negative regulation of cellular senescence in NB through the P53 pathway. The gene discussed is CENPA; the disease is neuroblastoma.